Alexandria Achieves 91% Megacampus Occupancy, Draws Lawsuit Over Revenue and FFO Claims

AREARE

Alexandria Real Estate reported 91% Megacampus occupancy—18% above market—in Greater Boston, San Francisco Bay and San Diego, accounting for 71% of annual rental revenue. Rosen Law Firm alleges the company misled investors on 2025 revenue, FFO and Long Island City leasing, with a Jan. 26, 2026 lead plaintiff deadline.

1. Alexandria Real Estate Celebrates 32 Years of Leadership

On January 5, 2026, Alexandria Real Estate Equities marked its 32nd anniversary since its founding in a Pasadena garage in 1994. The S&P 500® life science REIT has grown into a company with a $27.8 billion market capitalization and an asset base of 39.1 million rentable square feet of operating properties, plus 4.2 million RSF of Class A/A+ developments underway. Its signature Megacampus™ ecosystems in Greater Boston, the San Francisco Bay Area and San Diego accounted for 71% of annual rental revenue as of September 30, 2025, with occupancy at 91%—18 percentage points above average market levels. From January 1, 2023, through September 30, 2025, Alexandria leased more space in those three markets than the next five largest life science landlords combined, totaling 105% of their aggregate volume. Tenant retention has averaged over 80% for five consecutive years.

2. Alexandria Advances Precision Medicine Through MAP-D Partnership

As part of its 2026 priorities, Alexandria launched the Multi-Level Assessment & Phenotyping in Depression (MAP-D) program in collaboration with the Foundation for the National Institutes of Health. Major depressive disorder affects more than 21 million U.S. adults annually and imposes a $380 billion economic burden each year. With the design phase complete, the clinical study is slated to begin in May, coinciding with Mental Health Awareness Month. MAP-D aims to validate biomarkers that enable personalized diagnosis and treatment, reflecting Alexandria’s commitment to fostering public-private research partnerships that accelerate therapeutic breakthroughs.

3. Rosen Law Firm Files Securities Class Action Against Alexandria

Rosen Law Firm has filed a securities class action on behalf of investors who purchased Alexandria securities from January 27, 2025, through October 27, 2025. The complaint alleges that Alexandria issued materially false and misleading statements regarding revenue growth, funds from operations projections and the leasing value of its Long Island City property. Investors wishing to serve as lead plaintiff must file a motion by the January 26, 2026 deadline. The suit seeks recovery on a contingency fee basis and emphasizes that no out-of-pocket fees are required for class members.

Sources

PG